Estrogens prevent metabolic dysfunctions induced by circadian disruptions in female mice

Endocrinology

Volumn 156, Issue 6, 2015, Pages 2114-2123

  Zhu, Liangru ^a,c   Zou, Fang ^a   Yang, Yongjie ^a   Xu, Pingwen ^a   Saito, Kenji ^a   Hinton, Antentor Othrell ^a   Yan, Xiaofeng ^a   Ding, Hongfang ^a   Wu, Qi ^a   Fukuda, Makoto ^a   Sun, Zheng ^a,b   Tong, Qingchun ^a   Xu, Yong ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CIRCADIAN RHYTHM SIGNALING PROTEIN; CRYPTOCHROME 1; CRYPTOCHROME 2; ESTRADIOL; FATTY ACID SYNTHASE; GLUCOSE; INSULIN; PER2 PROTEIN; PER3 PROTEIN; PERILIPIN; PROTEIN; UNCLASSIFIED DRUG; ESTROGEN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CIRCADIAN DISRUPTION; CIRCADIAN RHYTHM; CONTROLLED STUDY; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FAT MASS; FEMALE; FEMALE ANIMAL; FOOD INTAKE; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HORMONAL THERAPY; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; LIPID STORAGE; MOUSE; NONHUMAN; OBESITY; OSCILLATION; PRIORITY JOURNAL; SYSTEMIC DISEASE; WHITE ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE; ADIPOSE TISSUE, WHITE; ANIMALS; CIRCADIAN RHYTHM; ESTROGENS; FEMALE; MICE; MICE, INBRED C57BL;

EID: 84930437229     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1922     Document Type: Article

References (49)

1. Huang W, Ramsey KM, Marcheva B, Bass J. Circadian rhythms, sleep, and metabolism. J Clin Invest. 2011;121:2133-2141.
2. Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science. 2010;330:1349-1354.
3. Spiegel K, Tasali E, Leproult R, Van Cauter E. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol. 2009;5:253-261.
4. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA. 2009;106:4453-4458.
5. Fonken LK, Workman JL, Walton JC, et al. Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci USA. 2010;107:18664-18669.
6. Karatsoreos IN, Bhagat S, Bloss EB, Morrison JH, McEwen BS. Disruption of circadian clocks has ramifications for metabolism, brain, and behavior. Proc Natl Acad Sci USA. 2011;108:1657-1662.
7. Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010;72:517-549.
8. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature. 2002;418:935-941.
9. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42:105-116.
10. Woon PY, Kaisaki PJ, Bragança J, et al. Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci USA. 2007; 104:14412-14417.
11. Scott EM, Carter AM, Grant PJ. Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int J Obes (Lond). 2008;32:658-662.
12. Drewett RF. Sexual behaviour and sexual motivation in the female rat. Nature. 1973;242:476-477.
13. Blaustein JD, Wade GN. Ovarian influences on the meal patterns of female rats. Physiol Behav. 1976;17:201-208.
14. Wallen WJ, Belanger MP, Wittnich C. Sex hormones and the selective estrogen receptor modulator tamoxifen modulate weekly body weights and food intakes in adolescent and adult rats. J Nutr. 2001; 131:2351-2357.
15. Geary N, Asarian L, Korach KS, Pfaff DW, Ogawa S. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-α null mice. Endocrinology. 2001;142:4751-4757.
16. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-αknockout mice. Proc Natl Acad Sci USA. 2000;97:12729-12734.
17. Bjorntorp P. Hormonal control of regional fat distribution. Hum Reprod. 1997;12(suppl 1):21-25.
18. Björntorp P. Obesity. Lancet. 1997;350:423-426.
19. Björntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition. 1997;13:795-803.
20. Kotani K, Tokunaga K, Fujioka S, et al. Sexual dimorphism of agerelated changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord. 1994;18:207-202.
21. Xu Y, Nedungadi TP, Zhu L, et al. Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab. 2011;14:453-465.
22. Morin LP, Fitzgerald KM, Zucker I. Estradiol shortens the period of hamster circadian rhythms. Science. 1977;196:305-307.
23. Albers HE. Gonadal hormones organize and modulate the circadian system of the rat. Am J Physiol. 1981;241:R62-66.
24. Wollnik F, Turek FW. Estrous correlated modulations of circadian and ultradian wheel-running activity rhythms in LEW/Ztm rats. Physiol Behav. 1988;43:389-396.
25. Perrin JS, Segall LA, Harbour VL, Woodside B, Amir S. The expression of the clock protein PER2 in the limbic forebrain is modulated by the estrous cycle. Proc Natl Acad Sci USA. 2006;103: 5591-5596.
26. Nakamura TJ, Moriya T, Inoue S, et al. Estrogen differentially regulates expression of Per1 and Per2 genes between central and peripheral clocks and between reproductive and nonreproductive tissues in female rats. J Neurosci Res. 2005;82:622-630.
27. Nakamura TJ, Sellix MT, Kudo T, et al. Influence of the estrous cycle on clock gene expression in reproductive tissues: effects of fluctuating ovarian steroid hormone levels. Steroids. 2010;75:203-212.
28. Zhu L, Yang Y, Xu P, et al. Steroid receptor coactivator-1 mediates estrogenic actions to prevent body weight gain in female mice. Endocrinology. 2013;154:150-158.
29. Lee S, Donehower LA, Herron AJ, Moore DD, Fu L. Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS One. 2010;5:e10995.
30. Xu Y, Berglund ED, Sohn JW, et al. 5-HT2CRs expressed by proopiomelanocortin neurons regulate insulin sensitivity in liver. Nat Neurosci. 2010;13:1457-1459.
31. Hill JW, Xu Y, Preitner F, et al. Phosphatidyl inositol 3-kinase signaling in hypothalamic proopiomelanocortin neurons contributes to the regulation of glucose homeostasis. Endocrinology. 2009;150: 4874-4882.
32. Bookout AL, Mangelsdorf DJ. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal. 2003;1:e012.
33. Gao Q, Mezei G, Nie Y, et al. Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat Med. 2007;13:89-94.
34. Rogers NH, Perfield JW 2nd, Strissel KJ, Obin MS, Greenberg AS. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology. 2009;150:2161-2168.
35. Attarchi M, Darkhi H, Khodarahmian M, et al. Characteristics of menstrual cycle in shift workers. Glob J Health Sci. 2013;5:163-172.
36. Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes Metab. 2008;34:317-327.
37. Davis KE, D Neinast M, Sun K, et al. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol Metab. 2013;2: 227-242.
38. Zhu L, Brown WC, Cai Q, et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes. 2013;62:424-434.
39. Maeda K, Cao H, Kono K, et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 2005;1:107-119.
40. Neculai D, Schwake M, Ravichandran M, et al. Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36. Nature. 2013;504:172-176.
41. Brasaemle DL, Subramanian V, Garcia A, Marcinkiewicz A, Rothenberg A. Perilipin A and the control of triacylglycerol metabolism. Mol Cell Biochem. 2009;326:15-21.
42. Griebel G, Ravinet-Trillou C, Beeske S, Avenet P, Pichat P. Mice deficient in cryptochrome 1 (cry1 (-/-)) exhibit resistance to obesity induced by a high-fat diet. Front Endocrinol (Lausanne). 2014; 5:49.
43. Grimaldi B, Bellet MM, Katada S, et al. PER2 controls lipid metabolism by direct regulation of PPARγ. Cell Metab. 2010;12:509-520.
44. Asarian L, Geary N. Estradiol enhances cholecystokinin-dependent lipid-induced satiation and activates estrogen receptor-α-expressing cells in the nucleus tractus solitarius of ovariectomized rats. Endocrinology. 2007;148:5656-5666.
45. Musatov S, Chen W, Pfaff DW, et al. Silencing of estrogen receptor α in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA. 2007;104:2501-2506.
46. Gallagher CJ, Langefeld CD, Gordon CJ, et al. Association of the estrogen receptor-α gene with the metabolic syndrome and its component traits in African-American families: the Insulin Resistance Atherosclerosis Family Study. Diabetes. 2007;56:2135-2141.
47. Sakka C, Efstathiadou ZA, Polyzos SA, Goutou M, Stakias N, Koukoulis GN. Associations of estrogen receptor α and β gene polymorphisms with sex steroid levels and body fat content in men. Exp Clin Endocrinol Diabetes. 2012;120:154-159.
48. Allende-Vigo MZ. Women and the metabolic syndrome: an overview of its peculiarities. P R Health Sci J. 2008;27:190-195.
49. Karlsson B, Knutsson A, Lindahl B. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med. 2001; 58:747-752.